MedPath

Clinical Validation for SpO2 Function of Masimo INVSENSOR00069

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: INVSENSOR00069
Registration Number
NCT06120777
Lead Sponsor
Masimo Corporation
Brief Summary

Assess the accuracy of INVSENSOR00069's peripheral oxygen saturation (SpO2) against contemporaneous measurement from arterial blood gas (ABG) analysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
89
Inclusion Criteria

Influenced by study design:

  • Subject is 18 to 50 years of age.
  • Subject weighs a minimum of 110 lbs.
  • Hemoglobin value ≥ 11 g/dL.
  • Baseline heart rate ≥ 45 bpm and ≤ 90 bpm.
  • Systolic blood pressure ≤ 140 mmHg and ≥ 90 mmHg and diastolic blood pressure ≤ 90 mmHg and ≥ 50 mmHg. If systolic blood pressure is lower than 100 mmHg and/or diastolic blood pressure is lower than 60 mmHg, subject passes an orthostatic blood pressure test.
  • CO value ≤ 3.0% FCOHb.
  • Subject is comfortable to read and communicate in English*. *This is to ensure the subject can provide informed consent (as study materials are currently available in English only) and can comply with study procedures.
Exclusion Criteria

Influenced by device warning labels:

  • Subjects with a skin condition affecting the digits, where the sensor is applied, which would interfere with the path of light (e.g., psoriasis, vitiligo, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, etc.).
  • Subjects with nail polish or acrylic nails on the digits where sensor needs to be applied, who opt not to remove them.
  • Subject has hemoglobinopathies or synthesis disorders (e.g., thalassemia, sickle cell disease).
  • Subject has a peripheral vascular or vasospastic disease (e.g., Raynaud's disease).

Influenced by study design/environment:

  • Subjects who do not pass the health assessment for safe participation in the study procedures.
  • Difficulty inserting an intravenous line in the subject's hand or arm and/or an arterial line in the radial artery of the subject's wrist.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test SubjectINVSENSOR00069All subjects who are enrolled into the test group and participate in data collection have the Masimo INVSENSOR00069.
Primary Outcome Measures
NameTimeMethod
SpO2 Accuracy of Masimo INVSENSOR000691-3 hours

The SpO2 accuracy of Masimo INVSENSOR00069 was determined by calculating the accuracy root mean-squared (Arms) difference between the measured values (SpO2) to the reference values (SaO2) in accordance with ISO-80601-2-61.

Arms= √(∑(i=1 to n) ((SpO2_i-SaO2_i )\^2 ))/n.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Masimo Corporation

🇺🇸

Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath